Vizgen, Ultivue Merge, Further Consolidating Spatial Biology
Combined company will offer both single-cell spatial genomics and multiplex proteomic profiling technologies
The two largest private companies in the growing spatial biology segment, Vizgen and Ultivue, said they have merged into a single entity that will offer both single-cell spatial genomics and multiplex proteomic profiling technologies to customers engaged in foundational and clinical research.
The combined company—which will carry the Vizgen name—will build upon its namesake predecessor’s expertise in single-cell spatial genomics and Ultivue’s leadership in multiplex proteomic profiling. The new Vizgen also aims to increase its presence in clinical lab settings while continuing to serve customers in research institutions and biopharmas.